3,378 Views
HIV/TB/STD
Pediatric ID
Adult ID
Epi/Infection Control
Global ID
Trainee
Interactive
At the conclusion of this session, participants will be able to:
Vance Fowler, Jr., MD, MHS
Professor of Medicine
Duke University
Durham, North Carolina
Disclosure: Green Cross, Cubist, Cerexa, Durata, Theravance
Debiopharm: Educational fees, Other Financial or Material Support
MedImmune, Cerexa/Forest/Actavis/Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Cubist/Merck
Medical Biosurfaces
Locus
Affinergy
Contrafect
Karius
Genentech, Regeneron, Basilea: Research Grant
Pfizer, Novartis, Galderma, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Cubist, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny.: Consultant
UpToDate: Other Financial or Material Support, Royalties
Jennifer Pisano, MD
Assistant Professor
University of Chicago
Chicago, IL
Disclosure: Nothing to disclose
Matthew Scarborough, MRCP, FRCPath, PhD
Consultant physician in Clinical Infection
Oxford University Hospitals, UK
Headington, Oxford, United Kingdom
Disclosure: Nothing to disclose
Patty Wright, MD
Professor
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Cumberland Pharmaceuticals: Advisory Board
Patrick Joseph, MD
Associate Clinical Professor
University of California, San Francisco
San Ramon, CA
Disclosure: Nothing to disclose
Susan Bleasdale, MD
Associate Professor, Medical Director IC&ASP
University of Illinois
Chicago, IL
Disclosure: Nothing to disclose